August 18-19, 2020
12:00 - 19:00 GMT

Covid-19 Virtual 2020

Theme: To Abolish the Corona Virus from the World
Speakers / August 2020
Oral presentation for Covid-19 Virtual 2020
David Hoffman Van Thiel

Advanced liver & Gastrointestinal Disease Center, USA

Biography
Title:
A Novel Approach to Terminate the COVID-19 Pandemic
Biography
Dr. David Hoffman Van Thiel majored in chemistry at Pomona College in California and obtained his MD from the University of California Los Angeles in 1963. He completed a year of pathology training between his second and third year of medical school. His house officer training occurred at the Cornell University in NYC from 1963-1965 and Boston University between1967-1969 having been interrupted for 2 years of government service at the NIH. Following his training, he spent 20 years at the University of Pittsburgh as a professor of medicine and developed 5 different liver transplant programs published >1100 peer –reviewed papers.
Oral presentation for Covid-19 Virtual 2020
Dan Jiang

Hallam Institute of TCM, UK

Biography
Title:
Diagnosis and Management on Infected or Suspected Patients with Covid-19---48 Cases study in UK
Biography
Ms Dan Jiang, TCM consultant, MMedSci, Fellowship of British Acupuncture Council (FBAcC), Fellowship of Association of Traditional Chinese Medicine UK (FATCM), Visiting professor and special appointed TCM consultant in Beijing University of Chinese Medicine; Visiting professor and supervisor for the oversea Ph.D students in Nanjing University of Chinese medicine; TCM consultant awarded by World federation of Chinese medicine societies (WFCMS).   Ms Dan Jiang studied western scientific and traditional Chinese medicines in Beijing university of Chinese medicine in Chinaand graduated for bachelor in 1978 and master of medical degrees in 1982 and 1987, who have been practicing TCM in UK since 1991. The chief author and editor for the book ‘Principle and Practice of Chinese medicine in the West’, the author for the book ‘Principle and Practice of TCM on Infertility in the West’ etc, more than 40 articles are published in the international medical journals in which 6 in SCI journals; TCM consultant for Euro-Sino researchers group of GP-TCM.
Oral presentation for Covid-19 Virtual 2020
Tahani ALSiari

Univerity of Glasgow, UK

Biography
Title:
The Validation of High-throughput Novel Drug Screening in Trichomonas Vaginalis
Biography
 Tahani Alsiari PhD Candidate at the University of Glasgow, Glasgow, United Kingdom. Graduated as MSc in 2016 from Long Island University, New York, United State. Joined the research group of Prof. De Koning at the Institute of Infection, Immunity & Inflammation at university of Glasgow early 2019.
Oral presentation for Covid-19 Virtual 2020
Jing-Yan Han

Peking University, China

Biography
Title:
Ameliorating effect and mechanism of Ma-Xing-Shi-Gan-Decoction*, a compound Chinese medicine on pulmonary microcirculatory disturbance
Biography
Dr. Jing-Yan Han is tenured professor and chairman of department of integration of Chinese and Western medicine, Peking university health science center. He is mainly engaged in the research of microcirculation and traditional Chinese medicine, focusing on the mechanism of microcirculatory disorder, organ injury and the ameliorating effects of traditional Chinese medicine.He has published more than 100 research articles in SCI journals.He is vice-president of China Society of Microcirculation and councilor member of International Liaison Committee for Microcirculation Research.
Oral presentation for Covid-19 Virtual 2020
Ziheng Zhang

Hong Kong Polytechnic University, Hong Kong

Biography
Title:
Biodegradable Wide-spectrum Anti-pathogenic Agent and its Applications
Biography
Dr. Ziheng Zhang studied Textile Chemistry at Donghua University, China and graduated as MS in 2012. He then joined the research group of Prof. Tao Xiaoming at the Institute of Textiles and Clothing of Hong Kong Polytechnic University. He received his PhD degree in 2020 at the same institution. He has published 6 research articles and 3 patents.
Oral presentation for Covid-19 Virtual 2020
Huang Wei Ling

Medical Acupuncture and Pain Management Clinic, Brazil

Biography
Title:
1. How can we treat Recurrent Herpes Virus Infection without the Use of Antiviral Drugs? 2. Can we Treat Urinary Tract Infections without Using Any Antibiotics?
Biography
Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress (1998). Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through teachings of Traditional Chinese Medicine and Hippocrates.
Oral presentation for Covid-19 Virtual 2020
Ahmed G. Hegazi

National research Center, Egypt

Biography
Title:
Establishment of the International Training Course on Apitherapy
Biography
African Federation of Apiculture Associations (AFAA), 2001- up till now, Secretary General. Journal of Bee keeping in Turkey (MELLIFERA), 2000 – up till now, Editorial Board Standing Commission on Apitherapy (APIMONDIA), 1999 - up till now, Member Muslim World League International Commission on Scientific Signs in the Qur'an & the Sunnah, Mecca, 2006, Member. Standing Scientific Committee, National Research Center, 1998 –up till now, Member International Apitherapy Health Care & Bee acupuncture Association (IAHB), 1997, Symposiarch International Apitherapy Health Care & Bee acupuncture Association (IAHBA), 1997, Council Member International Symposium on Apitherapy, 1997, Secretary General First, Second and Third Annual Conference of the Egyptian Association of Immunologists 1993, 1994 and 1996, Secretary General Egyptian Journal of Immunology, 1995, Editorial Board The Egyptian Association of Immunologists, 1992 –1997, Secretary General Journal of Biotechnology - Bulgaria, 1992, Editorial Board Referee in 69 International Journals Member of Standardization of bee products and sugar committee, Mainstay of Industry, 1998 Chairman of the Standardization of bee products and sugar committee, Mainstay of Industry, 2014 till now Member of Apitherapy, APIMONDIA, 1998 -2015 Chief Editor of the International Journal of Apitherapy Member of Animal wealth, Academy of Science and Technology, Egypt Chairman of the National Committee for Microbiological Sciences (NCMS) in Egypt, Academy of Science and Technology, Egypt
Oral presentation for Covid-19 Virtual 2020
Aykut Arif Topcu

Aksaray University, Turkey

Biography
Title:
How to bind a novel virus; SARS-CoV-2 on their host?
Biography
Dr. Aykut Arif Topcu studied at Medical Laboratory Program, Vocational Scholl of Health Service at Aksaray University, Turkey. He graduated as BA from Kırıkkale University in 2006 then received his PhD degree in 2015 at the same university, in Turkey. His research areas are related about the affinity chromatography and its application areas; preparation of cryogels for protein purification and removal of toxic metabolites and biosensing platforms to sense various analytes including clinic of interest. He is currently as an Assistant Professor at Aksaray University.
Oral presentation for Covid-19 Virtual 2020
Alan Talevi

Argentinean National Council of Scientific and Technical Research, Argentina

Biography
Title:
Application of Computer-Guided Drug Repurposing to the Discovery of New Potential Treatments for Infectious Diseases
Biography
Alan Talevi obtained his Pharmacy degree in 2004 and completed his PhD studies in 2007, both at the University of La Plata (UNLP, Argentina). He holds an Independent Researcher positionat the Argentinean Council of Science, and he is Lecturer of the Biopharmacy course at the Faculty of Exact Sciences, UNLP. He published over 70 articles and more than 30 book chapters related to machine learning and drug discovery. He was Head of the Department of Biological Sciences of the Faculty of Exact Sciences (2015-2017). Since 2018 he is Head of the Laboratory of Bioactive Research and Development (LIDeB, UNLP).
Oral presentation for Covid-19 Virtual 2020
Christian Aime Kayath

Marien Ngouabi University/IRSEN, Congo

Biography
Title:
Invasion of epithelial cells is correlated with secretion of Biosurfactant via the type 3 secretion system (SST3) of Shigella flexneri
Biography
Dr Christian Aimé Kayath studied at Marien N’gouabi University (Congo) and at the University of Liege (Belgium) graduated as D.E.S in 2005. He received PhD degree in 2010 at the University of Liege (Belgium). After teaching three years as Professor assistant at Free University of Brussels, He joined the Marien Ngouabi University as Researcher.  He is currently Head Manager in the Molecular Biology Lab of IRSEN and He is a senior Lecturer in Biochemistry and Molecular Biology since 2014 at the Marien Ngouabi University. He does research in Molecular characterization of Biomolecules like Biosurfactants and Bacteriocins. He also studies Bacteria-Bacteria Interactions and Host-Shigella Interations.
Oral presentation for Covid-19 Virtual 2020
Omotowo Babatunde

University of Nigeria, Nigeria

Biography
Title:
 Factors Influencing The Utilization of Prevention of Mother to Childtransmission of HIV (PMTCT) Services in Makurdi, Benue State, Nigeria
Biography
Dr Omotowo Babatunde obtained MBBS from University of Ilorin,  Nigeria in 1987. He completed MPH from University of Nigeria, Nsukka in 2006, and FWACP from West African College of Physicians in 2009. He joined the Department of Community Medicine, College of Medicine, University of Nigeria, Enugu Campus  as a Lecturer in August, 2012, later  became a Senior Lecturer in October, 2015. He was promoted as Associate Professor in October 2018. He was department MBBS Coordinator  from August, 2012 to October 2018. He has published some papers in both local and international journals. His interests are infectious and non-communicable diseases.
Oral presentation for Covid-19 Virtual 2020
Stelvin Sebastian

International society for infectious disease, India

Biography
Title:
Prevalence of Antibiotic Resistance in Escherichia Coli Isolates from Poultry Environment and UTI Patients in Kerala, India: A Comparison Study
Biography
EDUCATION:  Doctor of Pharmacy (Pharm D) – 71% Nirmala College of Pharmacy (2014-2020) Kerala University for Health And Science Thrissur, Kerala Diploma in Nutrition and Education - pursuing Indira Gandhi Open University, New Delhi Higher Secondary (2014) – 92% S.S.L.C ( 2012) – 96% WORK EXPERIENCE Aster Medicity Kochi (Clinical internship) - 3 month (Pulmonology, MICU, Urology, Neurology, CTVS, ILC) Nirmala Medical Centre - 12/6/15 to 20/10/19 General Hospital EKM - 1/07/18 - 01/08/18 (Oncology) Healthcloud AI - 2 month Clinical internship - medical history collection of the patients for Assisting doctors.
Oral presentation for Covid-19 Virtual 2020
Amel Belkhiri

University hospital center Blida. Algeria

Biography
Title:
Neuro-Occlusal Rehabilitation (NOR) And Prophylaxis of Periodontal Lesions
Biography
Amel Belkhiri is working as maître-assistant to orthodontics department at the University Hospital of Blida.He obtaining dental surgery degree in 1995. Then he worked as surgeon general to the health sector in the province of Illizi (Algeria) for two years. He obtaining the Diploma of higher medical study as a specialist in orthodontics and public health specialist in ODF in a dental clinic in Algeria in the year 2001.
Oral presentation for Covid-19 Virtual 2020
K. M. Yacob

Marma Health Centre, Kochi, Kerala, India

Biography
Title:
Fever is not a symptom in covid-19. 
Biography
We have been hearing for centuries that ‘fever is not a disease but a symptom’. Physicians say that fever is a symptom of diseases like flu to cancer. The conservative fever definition, diagnosis, and treatments are based on fever as a symptom. All the studies related to fever as a symptom of a disease have been done without knowing the Purpose of the temperature of fever is.   Without knowing the Purpose of the temperature of fever, how can fever included in the symptom definition?  Temperature between 38o to 41o centigrade can be symptom of a disease?     Most of the diseases may not have a fever. Sometimes it disappears. Then, is fever a symptom of which disease?   Symptom Definition is the only parameter necessary for a Symptom. As with any or all other definitions, symptom definition should describe the symptom scientifically. If it cannot describe clearly, there is no use of a symptom definition. A symptom is a departure from normal function or feeling which is noticed only by a patient, indicating the presence of disease or abnormality. One cannot be understood directly the temperature is elevated in the hypothalamus. A mechanical device is necessary to measure elevated temperature in the hypothalamus. In symptom definition, fever definition can’t be found. The elevation of body temperature is not included in symptom definition. Different cause of diseases never shows the same symptoms.          Different causes of diseases like virus, bacteria, fungi, venom, horror scene, horror dream,... never shows the same symptoms. Its actions are different and sometimes opposite. No similarities can be seen between their actions.   Elevated temperature or increased temperature never make fever or symptoms of fever. It may create hyperthermia. None of the diseases or causes of diseases require fever as its symptom.    If the mosquito bites its virus, bacteria, venom gets deposited in the body as a result according to nature and strength of Viruses, bacteria, venom symptoms like itching, pain, and signals like colour change, inflammation may occur.  we can see the symptoms, Signals, and indications of the virus, bacteria, the venom which multiple or spreading or damages(disease) the body before fever emerge. Patients who have flu to cancer may not have a fever.     How can we separate symptoms of the disease and symptoms of fever and symptoms of rising temperatures?   In fever, both symptoms of disease and symptoms of Fever are included. Deduct symptom of disease from total symptoms, we will get symptoms of fever.   (Disease +Fever)- Disease =Fever. (Symptoms of disease +Symptoms of Fever)- Symptoms of disease =Symptoms of Fever (bitter taste, body pain, fatigue to mind and body, reduced appetite, reduced motion and indigestion, internal and external discomfort,…)     Like that we can separate signs, signals, and actions of both fever and disease.   (Signals of disease +Signals of Fever) - Signals of disease =Signals of Fever(high temperature, shivering, unconscious,....)   (Signs of disease +Signs of Fever) - Signs of disease =Signs of Fever.   (Actions of disease +Actions of Fever) - Actions of disease =Actions of Fever. In fever  does not show any actions of temperature rise.
Oral presentation for Covid-19 Virtual 2020
Carlos M. Valdemar-Aguilar

Universidad Nacional Autónoma de México

Biography
Title:
Microbial-mimicking mesoporous silica: An adjuvant system proposal
Biography
Vaccination represents one of our greatest weapons against infectious diseases.  However, there is a need for optimizing vaccine potency, safeness and stability. Subunit vaccines have proven to be more stable and safer than live attenuated vaccines, but they lack the potency to evoke a correct immune response. Nanoparticles have been used in biomedical applications due to certain properties like shape, surface reactivity, and size. Among them, inorganic nanoparticles like those of mesoporous silica have gained interest due to their biocompatibility, absorbance/encapsulation capability, and easiness of functionalization. We designed a new carrier composed of mesoporous silica particles known as SBA-15 (Santa Barbara Amorphous-15), modified with a surface lipid bilayer (SLB) that displays an amphipathic lipid with adjuvant capabilities. The particles were synthesized by condensation of tetra-ethyl-ortho silicate in the presence of Pluronic 123. Phosphatidylinositol mannosides (PIMs), which are known to be TLR-2 agonists from mycobacteria, were isolated and assembled within SLB. Cationization of SBA-15 particles with amine groups was performed in order to promote the electrostatic interaction between silica and the negative phospholipid bilayers. Electron microscopy, raman spectroscopy, zeta potential, and Fourier transform infrared (FTIR) analyses were used to characterize the as-obtained particles, and their interaction with THP-1 macrophages was assessed through confocal and DIC microscopy. The biomimetic colloids, named PIM@SBA-15, showed biocompatibility towards human fibroblasts and were found to colocalize with Toll-like receptor TLR-2 upon their incubation with THP1-derived macrophages. Furthermore, the particles induced the formation of pseudopods and were internalized into phagocytic cells. In all, these data suggest the usefulness of PIM@SBA-15 particles to better comprehend the interactions between immune cells and PIMs.
Oral presentation for Covid-19 Virtual 2020
Mirna Ayshoa

Indevr, USA

Biography
Title:
Accelerating Development of COVID-19 Vaccines Using InDevR’s Novel- VaxArray Coronavirus SeroAssay
Biography
Dr. Mirna Ayshoa has been integral in leading the research and development and transfer to manufacturing of InDevR products since 2006. Dr. Mirna manages InDevR’s cross-functional R&D and Engineering departments, guiding and overseeing the development of the company’s extensive technology portfolio and related intellectual property.Dr. Mirna earned her Ph.D. in Analytical Chemistry from The University of North Carolina at Chapel Hill, holds a B.S. (summa cum laude) from Hartwick College in Oneonta, NY, and completed her postdoctoral training at the University of Colorado at Boulder. Ayshoa has published a wide number of high impact scientific publications and is a named inventor on numerous issued or pending patents.
Oral presentation for Covid-19 Virtual 2020
Nedelcu N I

Victor Babes Hospital, Romania

Biography
Title:
Approaches to the Termination of the COVID-19 Pandemic
Biography
Will Update Soon
Oral presentation for Covid-19 Virtual 2020
Lorena Abadia-Patino

Eastern University, Venezuela

Biography
Title:
Pseudomonas aeruginosa biofilm inhibition by propolis
Biography
Dr. Lorena Abadia-Patino studied Bio analysis at the Orient University, Venezuela and graduated in 1997. In 1998, she went to Paris to did aMicrobiology Master and Ph. D at Denis Diderot University and her work at Pasteur Institute under the direction of Patrice Courvalin. She got her Ph. D in 2003; returned to Venezuela and joined the research group of Biomedicine department at IIBCAUDO, created the BacterialResistance Laboratory. At present, she has the position of an Associated Professor at the UDO. She has published several papers, chapters and books. Associated editor of The Journal of Infection in Developing Countries.
Oral presentation for Covid-19 Virtual 2020
Muhammad Akram

Government College University Faisalabad, Pakistan

Biography
Title:
Evaluation of antioxidant effects and inhibitory activity of medicinal plants against lipid peroxidation induced by iron and sodium nitroprusside in mice brain. International Conference of Biochemistry, Biotechnology and Biomaterials
Biography
Hyperuricemia, Xanthine oxidase inhibition by some selected medicinal plants, Enzyme Inhibition, Study of traditional system medicine (Indusyunic Medicine) Phytochemistry, and poisonous plants. Bioactivity and phytopharmaceutical evaluation of herb drugs and their natural products, Medicinal plants and Clinical trial, Biochemistry, Bioinformatics
Oral presentation for Covid-19 Virtual 2020
Sudha Bansode

Shankarrao Mohite College, India

Biography
Title:
Food and nutritional proteomics
Biography
“Nutritional proteomics” by identifying and quantifying the proteins and their changes in a certain organ or tissue dependent on the food intake by utilizing a mass spectrometry-based proteomics technique. Purpose: Food intake is essentially important for every life on earth to sustain the physical as well as mental functions. The outcome of food intake will be manifested in the healthy state and its dysfunction. The molecular information about the protein expression change caused by diets will assist us to understand the significance of functional foods. We wish to develop nutritional proteomics to promote a new area in functional food studies for a Better Understanding of the role functional foods in health and disease
Oral presentation for Covid-19 Virtual 2020
Mandana Behbahani

University of Isfahan, Iran

Biography
Title:
In silico Design of novel Multi-epitope recombinant Vaccine based on Covid-19 surface glycoprotein
Biography
It is of special significance to find an effective vaccine against coronavirus disease 2019 (COVID-19) that can induce T cell and B cell mediated immune responses.  There is currently no vaccine to prevent  COVID-19  . In this study, a novel multiepitope vaccine for  COVID-19  virus based on surface glycoprotein was designed through application of bioinformatics approaches. At the first, eight potent linear B-cell and T-cell binding epitopes from surface glycoprotein were predicted in silico, then the epitopes were joined together via KK linker. The ability of the selected epitopes to induce interferon-gamma was assessed using IFNepitope web server.  Four final vaccines without and with three adjuvants (β-defensin, TcpA, CTxB) were constructed which composed of 89, 138, 113, 215 amino acids. Physicochemical properties, as well as antigenicity in the proposed vaccines, were checked for defining the vaccine stability and its ability to induce cell-mediated immune responses. Three-dimensional structure of the best vaccine was subjected to the molecular docking studies with MHC-I and MHC-II molecules. The results proposed that the multi-epitope vaccine without adjuvant  is a stable construct  with high antigenicity.
Oral presentation for Covid-19 Virtual 2020
Adarsh Kancharla

Sri Ramachandra Institute of Higher Education and Research, India

Biography
Title:
Impact of Sars- Cov2 pandemic on the management of children with cancers – A retrospective single centre study from a developing country
Biography
Purpose or Background:Knowing that more than 80% of pediatric malignancies are curable, the main challenges for pediatric oncologists remained to be the timely delivery of chemotherapy during this SARS CoV2 pandemic. We present data from our centre on the impact of pandemic on management of children with cancers. Method or Case: Our hospital caters to nearly 100 newly diagnosed pediatric malignancies annually. Ours is unique as we have a separate subsidized ward where same care is given through insurance and NGO support for patients from low socioeconomic status. Of the 342 admissions after the onset of pandemic, screening for the child and mother were done for 82 admissions. We studied this population with the aim of assessing the impact of management Results or Progress: Of the 17 new children diagnosed with various cancers, only 58% initiated treatment. Treatment default numbers had gone up to 12 children in 3 months, whereas the previous default rate was only one in past 3 months. Financial reasons and fear of acquiring infection remained the most common reason to default despite support from NGO and cancer relief fund support from the institution. Shared care with pediatricians and nearby pediatric oncologists was sought to keep the treatment ongoing. Those who tested positive (4.1% of those tested) were quarantined at home/ hospitalized for 2 weeks and were started on chemotherapy after repeat testing. All were asymptomatic and among those with symptoms of fever or respiratory complaints, none were positive. No morbidity or mortality was noted in this cohort Conclusion or Discussion: There were no increase in COVID related medical complications. The impact was indirect in form of treatment default, delay in chemotherapy and significant increase in cost of care. It is safe to run Pediatric oncology in developing countries with appropriate precautions, shared care and adequate funding.
Oral presentation for Covid-19 Virtual 2020
Adam Wisniewski

Nicolaus Copernicus University in Torun, Poland

Biography
Title:
Safety and efficacy of fibrinolytic therapy in ischemic stroke with unclear time of onset
Biography
Dr. Adam Wiśniewski is currently working as Assistant Professor in Department of Neurology at Collegium Medicum in Bydgoszcz, Nicolaus Copernicus  University in Toruń, Poland. He received his Medicine Doctor degree on December, 2018 from  Nicolaus Copernicus  University in Toruń, Poland. From 1 October 2019- the Head of Stroke Intensive Unit in Department of Neurology, The University Hospital No 1 in Bydgoszcz, Poland. Dr. Wiśniewski has authored several relevant publications in respective peer-review journals. His publications reflect his research interests in relationships between stroke and platelet reactivity. He is a member of American Heart Association/ American Stroke Association- Stroke Council, European Stroke Organisation, World Stroke Organisation, and European Academy of Neurology.
Oral presentation for Covid-19 Virtual 2020
Ji Yong Lee

H Plus Yangji Hospital, Korea

Biography
Title:
Walk-Through screening system for COVID-19
Biography
Dr. Lee received Medical Degree from the Eulji University. He completed internship and residency training in Internal Medicine at Kangbuk Samsung Hospital, Sungkyunkwan University and fellowship training in Division of infectious disease, Department of Internal medicine at Samsung Medical Center, Sungkyunkwan University. Now he is the Director of the Division of infectious disease, Department of Internal medicine, and the manager of infectious control team of H Plus Yangji Hospital since 2016.
Oral presentation for Covid-19 Virtual 2020
Gesivaldo Santos

State University of Southwestern Bahia(UESB), Brazil

Biography
Title:
s-APP-alpha peptide as a possible new target in Alzheimer’s Disease treatment: a theoretical approach
Biography
Will Update Soon...
Oral presentation for Covid-19 Virtual 2020
Clara I McCarthy

Multidisciplinary Institute of Cell Biology, Argentina

Biography
Title:
Studying the effects of antipsychotic drugs on a non-canonical target, the D1/D5R constitutive activity in PFC neurons
Biography
Clara McCarthy’s Short Biography   Soon after obtaining my Bachelor Degree in Biological Sciences, I started my PhD studies in the Electrophysiology Lab of Dr. JesicaRaingo at the IMBICE Institute (La Plata, Argentina).My research project combines the study of dopamine-mediated activity with the exploration of the role of D1R constitutive activity and its effects onvoltage-gated calcium channels CaV2.2, to propose a compelling model that contributes to our understanding of D1R function in the prefrontal cortex (PFC). I am especially interested in D1R activity in the cortico-basal ganglia circuit, where dopamine and its receptors play an important yet not fully understood role. 
Oral presentation for Covid-19 Virtual 2020
Francisco Capani

Institute of Research in Cardiology (ININCA), Argentina

Biography
Title:
Neuroprotection in Brain Injury
Biography
I completed my PhD at the  Eduardo De Robertis Institute, School of Medicine-University of Buenos (UBA). I performed my postdoctoral studies at University of California San Diego andKarolinska Institute. for 8 years focusing my research on cell biology of dendritic spines combining electron tomography and 3-D reconstruction techniques.I returned to Argentina.in 2007 . Since then I applied my broad experience in electron microscopy to study the mechanisms involved in the pathophysiology of the perinatal asphyxia. I published 114 papers in reputed journals and has been invited in more than 21 international symposiums
Oral presentation for Covid-19 Virtual 2020
Sarah El-Nakeep

Ain Shams University, Egypt

Biography
Title:
COVID-19 gastrointestinal manifestations and treatment
Biography
Dr. Sarah El-Nakeep M.D. is an associate professor in Internal medicine, Faculty of medicine, Ain shams University, Egypt. She has an M.D. degree in internal medicine. She was a Sub-director of the Intermediate Gastroenterology ICU in Demerdash hospitals and interested in the genetic background of the diseases and their clinical link.
Oral presentation for Covid-19 Virtual 2020
Shyamapada Mandal

University of Gour Banga, India

Biography
Title:
Indigenous Probioticlactobacilli in Combating Bacterial Infection - The Insights
Biography
Will Update Soon...
Oral presentation for Covid-19 Virtual 2020
Rahul Hajare

Indian Council of Medical Research, India

Biography
Title:
Fry pan paediatric mother Pune University and followed depression direction worst living against of credit social distancing of Burnside mouth
Biography
Will Update Soon...
Oral presentation for Covid-19 Virtual 2020
Adeloye Opeyemi Oluwasanmi

University of medical sciences, Nigeria

Biography
Title:
Symbiotic relationship with gut microbiomes and Parkinson disease
Biography
Adeloye Opeyemi has completed his PhD at the age of 30 years from University of Jos and postdoctoral studies from University of Medical Science. He is the director and Founder of Rosad Neurodegenerative disease Research and Foundation Centre Jos, a non governmental organization. He has published more than 47 papers in reputed journals and has been attended different conferences, seminar and symposium home and abroad.
Oral presentation for Covid-19 Virtual 2020
Amarjeet Gambhir

Lady Hardinge Medical College & Hospital, India

Biography
Title:
Artificial Intelligence-An effective tool to combat COVID-19
Biography
Dr. AMARJEET GAMBHIR graduated in dentistry from GDC, Indore in 2002 & completed his post-graduation in Oral & Maxillofacial Surgery from NHDC, Mumbai in 2006. He completed his 3 year Senior Residency from Lady Hardinge Medical College & Hospital, New Delhi in 2009. He then worked as a faculty at different dental colleges and was promoted to Professor, Oral & Maxillofacial Surgery in 2016. He again joined Lady Hardinge Medical College as a Faculty in 2016. He has worked as a co-investigator in pilot project on school-based sealant programme 2017 under Ministry of Health & Family Welfare, Government of India. He is a reviewer of various international journals & has published more than 15 national & international papers in indexed journals. He has also authored 3 books for dental postgraduate entrance examinations.
Latest Tweets